Results 91 to 100 of about 3,471 (204)

Differences of therapeutic effects on regional bone mineral density and markers of bone mineral metabolism between alendronate and alfacalcidol in Japanese osteoporotic women [PDF]

, 2007
We studied the differences of therapeutic effects on regional bone mineral density (BMD) and markers of bone mineral metabolism between alendronate and alfacalcidol in Japanese osteoporotic women.
Yasui, Natsuo, 00157984, Abbaspour, Aziz, Yonezu, Hiroshi, ヤスイ, ナツオ, 安井, 夏生, 1520, 米津, 浩, タカタ, シンジロウ, Takata, Shinjiro, 60032/profile-ja.html, ヨネヅ, ヒロシ, 髙田, 信二郎   +12 more
core  

Five-year follow-up of a woman with pregnancy and lactation-associated osteoporosis and vertebral fractures

Therapeutics and Clinical Risk Management, 2012
Jun Iwamoto1, Yoshihiro Sato2, Mitsuyoshi Uzawa3, Hideo Matsumoto11Institute for Integrated Sports Medicine, Keio University School of Medicine, 2Department of Neurology, Mitate Hospital, Fukuoka, 3Department of Orthopaedic Surgery, Keiyu Orthopaedic ...
Sato Y, Uzawa M, Matsumoto H, Iwamoto J
doaj  

Superiority of alfacalcidol compared to vitamin D plus calcium carbonate in lumbar BMD in post menopausal osteoporosis

, 2005
In a randomized multicenter, double-blind, double-dummy, parallel group study a comparison of the efficacy and safety of 1 microg alfacalcidol to 880 IU vitamin D plus calcium carbonate (1 g calcium) once daily per os was performed on 148 postmenopausal ...
NUTI R, ORTOLANI S., D'ERASMO E, ORIENTE P, CAUDARELLA R, FIORE C, LUISETTO, GIOVANNI, ISAIA G, MURATORE M, BIANCHI G, BRANDI ML   +10 more
core  

Superiority of alfacalcidol compared to vitamin D plus calcium il lumbar bone mineral density in postmenopausal osteoporosis.

, 2005
In a randomized multicenter, double-blind, double-dummy, parallel group study a comparison of the efficacy and safety of 1 μg alfacalcidol to 880 IU vitamin D plus calcium carbonate (1 g calcium) once daily per os was performed on 148 postmenopausal
D'Erasmo E., Luisetto G., Fiore C., Oriente P., Isaia G.C., Muratore M., Ortolani S., Brandi M.L., CAUDARELLA, RENATA, Bianchi G., Nuti R.   +10 more
core  

Efficacy and safety of doxercalciferol (1α hydroxyvitamin D₂) on spine and femur bone mineral density in postmenopausal osteopenic women. [PDF]

Front Endocrinol (Lausanne)
Gallagher JC, Mazess R.
europepmc   +1 more source

Mechanistic actions of eldecalcitol and alfacalcidol across the muscle-metabolic axis: A selectivity perspective in sarcopenia and type 2 diabetes. [PDF]

iScience
Cambria MT, Campanella M, Russo C, Agafonova A, Surdo S, Valle MS, Malaguarnera L.   +6 more
europepmc   +1 more source

Alfacalcidol plus calcium versus cholecalciferol in glucocorticoid-exposed children with nephrotic syndrome: a randomized controlled trial. [PDF]

Clin Kidney J
Chen HR, Tang H, Zhang M, Lin JA, Lin XQ, Zhang JY, Lu JY, Xia HM, Gao X, Liao X.   +9 more
europepmc   +1 more source

Site-Specific Responses to SERM Treatment in Postmenopausal Osteoporosis: No Clear Age Attenuation in a Real-World Study. [PDF]

Medicina (Kaunas)
Nagai T, Hoshi E, Ishikawa K, Tsuchiya K, Tani S, Dodo Y, Sakamoto K, Kawate N, Kudo Y.   +8 more
europepmc   +1 more source

Prior treatment, not vitamin D, predicts romosozumab response in 314 osteoporosis patients: A retrospective cohort study. [PDF]

Bone Rep
Nakano R, Ichisawa A, Saruta K, Kogawa M, Fukuda A.   +4 more
europepmc   +1 more source

Alfacalcidol and hypercalcaemia. [PDF]

BMJ, 1987
openaire   +2 more sources